All Labs

Basic Science population science clinical research

Beck Group

The Beck Group focuses on improving patient outcomes including the symptom experience and quality of life in individuals with cancer.

Boucher Group

The Boucher Group is interested in applications of cancer biostatistics and mathematical modeling to areas, such as high-throughput genomics, carcinogenesis modeling and cancer epidemiology.

Buys Group

The Buys Group works in two related areas of cancer control: identification and management of those at increased risk for breast and other cancers; and screening and detection of cancer.

The main focus of research of the Camp Lab is the identification of germ-line genetic variants that increase susceptibility to disease, with specific interests in breast cancer, chronic lymphocytic leukemia, and multiple myeloma.

Cannon-Albright Group

The Cannon-Albright Group explores the genetics of cancer through the creation and analysis of large genealogical databases. We also study high-risk pedigrees to identify disease predisposition genes.

Curtin Group

The Curtin Group researches epigenetics in cancer, cancer epidemiology with emphasis on colorectal cancer, environmental pollution, and gene-environment interactions.

The Doherty Group researches ---

Factor Group

The Factor Group researches the biology and prevention of breast cancer.

Fluchel Group

The Fluchel Group research focuses on assessing the impact of geography on the morbidity, mortality, and the burden of care in pediatric oncology patients with the goal of developing methods to better serve patients from rural, immigrant, and underserved communities.

Goldgar Group

The Goldgar Group website is coming soon.

The Hashibe Group focuses on the molecular and global epidemiology of cancers of the head and neck, lung, testis, ovary, colorectum and breast. The goals of our research are to identify genetic and lifestyle risk factors for cancer, and to evaluate the long-term health effects among cancer survivors.

Hu Group

The Hu Group is interested with biomarker, survival, and longitudinal data analyses in cancer.

Jensen Group

The Jensen Group is engaged in several projects related to skin cancer detection. This research has been funded by a Great Ideas in the Humanities grant provided by the College of Humanities at the University of Utah.

Kepka Group

The Kepka Group is engaged in population science research that addresses health disparities related to cancer risk in vulnerable populations, with the goal of driving quality improvement and increased access to primary health care services for cancer prevention and control among minority and underserved populations.

The Kirchhoff Group focuses on the social and financial consequences of cancer, primarily in adult survivors of childhood cancer.  We are interested in how late effects from cancer treatment impact socioeconomic outcomes for survivors.

Lowrance Group

The Lowrance Group focuses on understanding and improving clinical outcomes for patients with urologic cancers.

Mooney Group

The Mooney Group's science focus intersects the areas of cancer control and behavioral science. Key to our efforts is to understand and reduce morbidity from cancer and treatment related physical and psychosocial symptoms with an intent to improve patient reported outcomes.

Rupper Group

The Rupper Group research focuses on developing and evaluating clinical systems for surveillance of the medical decision-making needs of elderly patients and their caregivers, and to deliver appropriately personalized decision support.

Samowitz Group

The Samowitz Group website is coming soon.

Smith Group

The Smith Group research focuses on suspected psychosocial consequences of genetic testing, including psychological distress, sibling and spouse relationships, reproductive decision making, cancer screening behaviors, and cancer risk communications.

Sweeney Group

The Sweeney Group website is coming soon.

Ulrich group

The Ulrich Group studies lifestyle and genetic factors on carcinogenesis and cancer prognosis, and interactions between genetic predisposition, nutrition, and medication.

Wu Team

The goal of the Wu Group is to improve children’s health outcomes by promoting self-management and disease management. In particular, we are interested in improving adherence to medical regimens among children and among adolescents and young adults with cancer.